Antikörper gegen OPGL
European patent · EP2270052 · Deleted
Register entry
- Publication number
- EP2270052
- Application number
- EP10181323
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Jun 25, 2002
- Published
- Jan 5, 2011
- Granted
- Mar 28, 2018
- Deleted
- Jul 1, 2022
- Reason
- Maximum term reached
- IPC classes
- C07K 16/28 (2006.01)A61K 39/395 (2006.01)G01N 33/53 (2006.01)//A61P 19/08 (2006.01)
- Priority
- US 301172 P 26.06.2001
- Divided from
- EP09156995
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Jul 1, 2022
Maximum term reached
Published in Swissreg on 01.07.2022
- Sep 22, 2021
Transferred
- Owner
- Amgen, Inc., One Amgen Center Drive, Naukstio 27/4-A, Thousands Oaks, CA 91320, USA, Amgen Fremont Inc., One Amgen Center Drive, Thousand Oaks, CA 91320-1799, USA → Amgen, Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA, Amgen Fremont Inc., One Amgen Center Drive, Thousand Oaks, CA 91320, USA
Published in Swissreg on 22.09.2021
- Mar 28, 2018
Granted
Published in Swissreg on 28.03.2018
Parties
Holder
Inventor
Boyle, William
Malibu, CA 90265, US
Martin, Francis
Newbury Park, CA 91320, US
Corvalan, Jose
Foster City, CA 94404, US
Davis, Geoffrey
Burlingame, CA 94010, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.